...
首页> 外文期刊>Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology >Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution.
【24h】

Natural history of solitary cerebral cysticercosis on serial magnetic resonance imaging and the effect of albendazole therapy on its evolution.

机译:串行磁共振成像中孤立性脑囊虫病的自然病史以及阿苯达唑治疗对其演变的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

AIM: To describe the evolution of imaging characteristics of solitary cerebral cysticercal lesions (SCCL) on serial MRI, and to study the effect of treatment with albendazole. DESIGN: Randomised controlled prospective trial. METHODS AND MATERIAL: 123 patients with new-onset seizures and SCCL on contrast MRI were randomised to treatment with albendazole and followed with up to five serial MRIs. RESULTS: 81 patients (M - 41, F - 40) with mean age of 19.6+/-11.7years and 4 or 5 serial MRI were included in the analysis. Analysis was performed on 356 MRI's. Scolex was seen in 61.9% of patients in postcontrast T1 sequence in the first MRI study, and there was a significant drop in visibility from the next scan onwards. Cyst contents were initially T1-hypointense and T2-hyperintense with inversion on FLAIR in 30.8% and later scans showed T2-hypointensity. Cyst wall characteristics changed significantly from initially T2-hypointensity to later hyperintense rim. Initial scan revealed perilesional oedema in 98.5%, which is resolved by the second scan. Around 17.5% showed subtle perilesional T2-hyperintensity in follow-up scans. Enhancement pattern changed significantly from ring to disc, and later to non-enhancement. Initially, 69.7% lesions were in colloid-vesicular stage. Lesions moved through subsequent stages of cyst degeneration: time needed for this process is described. Imaging characteristics, both on the first and on subsequent scans, did not differ between albendazole and control groups. CONCLUSIONS: Evolution of SCCL follows a predictable sequence corresponding to morphologic stages described earlier, taking over a year to complete. Contrast enhancement decreases as degeneration progresses, but some calcific lesions continue to enhance. Albendazole therapy may hasten resolution of inflammation around the lesion but affects neither the morphology of the cysticercus nor the process of degeneration and subsequent healing.
机译:目的:描述串行MRI对孤立性脑胆囊病变(SCCL)成像特征的演变,并研究阿苯达唑治疗的效果。设计:随机对照的前瞻性试验。方法和材料:将123例新发癫痫发作和SCCL对比MRI患者随机分配到阿苯达唑治疗,随后进行五次连续MRI检查。结果:81例患者(M-41,F-40)平均年龄为19.6 +/- 11.7岁,并进行了4或5次连续MRI检查。分析在356 MRI上进行。在第一次MRI研究中,在对比度为T1序列的患者中,有61.9%的患者发现了Scolex,并且从下次扫描开始可见性明显下降。囊肿内含物最初为T1低蛋白和T2高蛋白,在FLAIR中转化率为30.8%,后来的扫描显示为T2低蛋白。囊壁特征从最初的T2低变到后来的高强度边缘发生了显着变化。初次扫描显示病灶周围水肿达到98.5%,第二次扫描已解决。在后续扫描中,约有17.5%的患者显示了病灶周围的T2细微变化。增强模式从响到圆盘,后来又变成了非增强,变化很大。最初,69.7%的病变处于胶体囊泡期。病变移动至囊肿变性的后续阶段:描述了该过程所需的时间。阿苯达唑和对照组之间在第一次和随后的扫描中的成像特征没有差异。结论:SCCL的进化遵循可预测的序列,对应于先前描述的形态学阶段,需要一年多的时间才能完成。随着变性的进行,对比度增强降低,但是一些钙化病变继续增强。阿苯达唑治疗可加快病变周围炎症的消退,但既不影响囊肿的形态,也不影响变性和随后的愈合过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号